Skip to main content
Clinical Trials/NCT04694118
NCT04694118
Unknown
Not Applicable

Comparison of the Effectiveness of Walking Back Exercises and Rebound Therapy in Cerebral Palsy Rehabilitation

Istanbul Medipol University Hospital2 sites in 1 country30 target enrollmentJanuary 4, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cerebral Palsy, Spastic
Sponsor
Istanbul Medipol University Hospital
Enrollment
30
Locations
2
Primary Endpoint
changes in muscle volume
Last Updated
5 years ago

Overview

Brief Summary

Purpose of the study:

To investigate the effect of walking back exercises and rebound therapy on muscle strength, functionality, balance and aerobic capacity in children with CP Implication for rehabilitation:Determining the effects of rehabilitative interventions (back and forth walking exercises and rebound therapy) to be applied in children with CP with objective measurement methods (muscle US, tetrax balance system) and evaluating the effects of the results on functionality and respiratory parameters

Detailed Description

Inclusion Criteria: Being diagnosed with SP To be in the age range of 6-15 years, where effective communication can be provided in evaluation and treatment processes and when walking begins to mature Having adequate communication skills Being on level I or level II according to GMFM No impairment in visual functions in terms of not affecting postural control responses, Children with family consent Study design: Application of the evaluation methods specified at the beginning of the study to all 30 patients with CP who were randomly divided into 2 groups. Re-evaluations were planned 8 weeks after the first evaluation of all cases who were continuing with structured neurodevelopmental treatment programs. In addition to the ongoing structured neurodevelopmental treatment programs; Group 1: 12 weeks / 3 days 20 minutes walking back exercises on normal ground, Group 2: Rebound therapy exercises, which are arranged according to the functional levels of the cases, will be applied in 12 weeks / 3 days for 20 minutes.

Registry
clinicaltrials.gov
Start Date
January 4, 2021
End Date
December 15, 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Istanbul Medipol University Hospital
Responsible Party
Principal Investigator
Principal Investigator

ulkuatasoy2017

Msc.physiotherapist

Istanbul Medipol University Hospital

Eligibility Criteria

Inclusion Criteria

  • Being diagnosed with hemiparetic SP To be in the age range of 6-15 years, where effective communication can be provided in evaluation and treatment processes and when walking begins to mature Having adequate communication skills Being on level I or level II according to KMFSS No impairment in visual functions in terms of not affecting postural control responses, Children with family consent

Exclusion Criteria

  • Orthopedic surgery and / or botulinum toxin-A application for the lower extremity in the last 6 months Being at level III, level IV or level V according to KMFSS Severe convulsion situations that cannot be controlled with drugs Presence of a medical condition that prevents participation in the study Congenital malformation conditions accompanying CP

Outcomes

Primary Outcomes

changes in muscle volume

Time Frame: one measurement at the beginning of the study, second measurement 8 weeks later, 3rd measurement at 12th week following

ultrasonic imaging

Study Sites (2)

Loading locations...

Similar Trials